Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I De Vitis

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
European Review for Medical and Pharmacological Sciences|August 2, 2022
The prevalence of celiac disease and the appropriateness of the diagnosis in family medicine setting could be lower than expectedG M Giorgetti, I De Vitis, F Fabiocchi, et al.
European Review for Medical and Pharmacological Sciences|July 6, 2021
COVID-19 in celiac disease: a multicentric retrospective cohort studyG Gasbarrini, T Dionisi, G R Corazza, et al.
European Review for Medical and Pharmacological Sciences|February 24, 2006
Early atherosclerosis in patients with inflammatory bowel diseaseA Papa, S Danese, R Urgesi, et al.
Techniques in Coloproctology|June 12, 2008
Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn's disease with anal endosonographic monitoring: a single-centre experienceL Guidi, C Ratto, S Semeraro, et al.
Alimentary Pharmacology & Therapeutics|August 4, 2015
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up studyD Pugliese, L Guidi, P M Ferraro, et al.
Journal of Crohn'S & Colitis|June 8, 2012
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressantsG Andrisani, D Frasca, M Romero, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2005
Increased carotid intima-media thickness in patients with inflammatory bowel diseaseA Papa, A Santoliquido, S Danese, et al.
International Journal of Immunopathology and Pharmacology|February 9, 2005
Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatmentL Guidi, M Costanzo, M Ciarniello, et al.
European Review for Medical and Pharmacological Sciences|January 11, 2005
Clinical correlations of small bowel CT and contrast radiology findings in Crohn's diseaseL Guidi, L M Minordi, S Semeraro, et al.
Minerva Gastroenterologica E Dietologica|December 3, 2008
Diagnostic value of endoscopic markers for celiac disease in adults: a multicentre prospective Italian studyL Piazzi, L Zancanella, F Chilovi, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
European Review for Medical and Pharmacological Sciences|August 2, 2022
The prevalence of celiac disease and the appropriateness of the diagnosis in family medicine setting could be lower than expectedG M Giorgetti, I De Vitis, F Fabiocchi, et al.
European Review for Medical and Pharmacological Sciences|July 6, 2021
COVID-19 in celiac disease: a multicentric retrospective cohort studyG Gasbarrini, T Dionisi, G R Corazza, et al.
European Review for Medical and Pharmacological Sciences|February 24, 2006
Early atherosclerosis in patients with inflammatory bowel diseaseA Papa, S Danese, R Urgesi, et al.
Techniques in Coloproctology|June 12, 2008
Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn's disease with anal endosonographic monitoring: a single-centre experienceL Guidi, C Ratto, S Semeraro, et al.
Alimentary Pharmacology & Therapeutics|August 4, 2015
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up studyD Pugliese, L Guidi, P M Ferraro, et al.
Journal of Crohn'S & Colitis|June 8, 2012
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressantsG Andrisani, D Frasca, M Romero, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2005
Increased carotid intima-media thickness in patients with inflammatory bowel diseaseA Papa, A Santoliquido, S Danese, et al.
International Journal of Immunopathology and Pharmacology|February 9, 2005
Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatmentL Guidi, M Costanzo, M Ciarniello, et al.
European Review for Medical and Pharmacological Sciences|January 11, 2005
Clinical correlations of small bowel CT and contrast radiology findings in Crohn's diseaseL Guidi, L M Minordi, S Semeraro, et al.
Minerva Gastroenterologica E Dietologica|December 3, 2008
Diagnostic value of endoscopic markers for celiac disease in adults: a multicentre prospective Italian studyL Piazzi, L Zancanella, F Chilovi, et al.
Pageof 5